CJC-1295 – 25 mg

Brand:
Cayman
CAS:
446036-97-1
Storage:
-20
UN-No:
Non-Hazardous - /

CJC-1295 is a synthetic peptide derivative of growth hormone-releasing hormone (GHRH).{58178} Unlike CJC-1295-DAC, CJC-1295 does not contain a drug affinity complex (DAC) moiety and has a shorter half-life than the DAC-conjugated version in the blood.{58179} CJC-1295 increases the secretion of growth hormone in primary rat anterior pituitary cells when used from picomolar to micromolar concentrations and into rat blood when administered subcutaneously at a dose of 1 µmol/kg.{58178}  

 

Available on backorder

SKU: 32704 - 25 mg Category:

Description

A synthetic peptide derivative of GHRH; does not contain a DAC moiety, which reduces its half-life; increases the secretion of growth hormone in primary rat anterior pituitary cells when used from pM to µM concentrations; increases the secretion of growth hormone into rat blood at 1 µmol/kg, s.c.


Formal name: L-tyrosyl-D-alanyl-L-α-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-glutaminyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-L-alanyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-leucyl-L-seryl-L-argininamide

Synonyms:  CJC-1295-no DAC|GHRH (1-29)-NH2|Modified GRF (1-29)

Molecular weight: 3,367.90

CAS: 446036-97-1

Purity: ≥95%

Formulation: A crystalline solid